EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY-NC-ND 4.0

Pharmacodynamic Safety Endpoints for Propofol Anesthesia in Children by Age and Sex: A Multicohort Observational Study

Lindy Moxham, Aanisah Golam, Nicholas C West iD, Matthias Görges iD, Simon D Whyte iD

Pediatric Anesthesia · 2025

DOI: 10.1111/pan.70031 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Pediatric Anesthesia, 2025. Verfasst von Lindy Moxham und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Propofol, Anesthetics, Intravenous. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: BC Children's Hospital Research Institute, Michael Smith Health Research BC, BC Children's Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Propofol is a commonly used intravenous sedative and general anesthetic, with rapid onset and short duration of action. It has a narrow therapeutic index and significant interindividual variability in dosing requirements, which may elevate risks of its use, particularly in children.

Aims

We aimed to quantify the doses required to induce loss of consciousness and apnea in children by age and sex to contribute to tailored propofol dosing recommendations for improved safety and efficacy in pediatric anesthesia.

Methods

In this stratified‐ and purposive‐sampling study, we enrolled children in six groups based on sex and age (3‐ to 5‐year‐olds, 6‐ to 10‐year‐olds, 11‐ to 18‐year‐olds), targeting 60 participants per group. For induction of anesthesia, we administered propofol at a constant rate until apnea was reached (absence of end‐tidal CO 2 for 20 s) up to a maximum dose of 10 mg/kg. We measured the propofol dose required to reach pharmacodynamic endpoints, including loss of eyelash reflex (LOER) and apnea, and estimated the effect of sex and age on these doses.

Results

Data were available for 318 participants, with 162 females and a median (interquartile range) age of 8.1 (5.3–12.9) years. The mean (SD) propofol dose to LOER was 2.65 (0.69) mg/kg with no effect of sex (−0.10 mg/kg for male, 95% confidence interval (CI) –0.26 to 0.05, p = 0.183) or age (0.0 mg/kg per year, 95% CI –0.02 to 0.02, p = 0.876). The mean (SD) propofol dose to apnea was 6.82 (1.64) mg/kg, with significant effects of both sex (+0.67 mg/kg for male, 95% CI 0.30 to 1.03, p < 0.001) and age (−0.14 mg/kg per year, 95% CI –0.19 to −0.1, p < 0.001). Apnea was not reached in 62 participants.

Conclusions

Older and female children exhibited narrower therapeutic indices for the margin between LOER and apnea. This requires heightened vigilance, especially when maintaining spontaneous respiration. A planned genome‐wide association study may identify pharmacogenetic‐pharmacodynamic relationships and correlations with genetic ancestry. Trial Registration The trial was registered on clinicaltrials.gov before enrolment (NCT04164264; date of registration 2019‐11‐15)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PropofolAnesthetics, IntravenousHumansChildMaleFemaleChild, PreschoolAdolescentAge FactorsSex FactorsApneaDose-Response Relationship, Drug

Stichwörter der Autor:innen

age factorsethnicitypediatric anesthesiapropofolsafetysex

Substanzen

PropofolAnesthetics, Intravenous

Autor:innen und Institutionen

  • Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Research Institute, BC Children's Hospital, Vancouver, British Columbia, Canada.
  • Department of Anesthesia, BC Children's Hospital, Vancouver, British Columbia, Canada.
  • Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.

ORCID-Profile: Nicholas C West, Matthias Görges, Simon D Whyte

Förderung

  • BC Children's Hospital Research Institute
  • Michael Smith Health Research BC
  • BC Children's Hospital

Zitieren

APA

Moxham, L., Golam, A., West, N. C., Görges, M., & Whyte, S. D. (2025). Pharmacodynamic Safety Endpoints for Propofol Anesthesia in Children by Age and Sex: A Multicohort Observational Study. Pediatric Anesthesia. https://doi.org/10.1111/pan.70031

Vancouver

Moxham L, Golam A, West NC, Görges M, Whyte SD. Pharmacodynamic Safety Endpoints for Propofol Anesthesia in Children by Age and Sex: A Multicohort Observational Study. Pediatric Anesthesia. 2025. doi:10.1111/pan.70031

BibTeX
@article{Moxham2025,
  author = {Moxham, Lindy and Golam, Aanisah and West, Nicholas C and Görges, Matthias and Whyte, Simon D},
  title = {Pharmacodynamic Safety Endpoints for Propofol Anesthesia in Children by Age and Sex: A Multicohort Observational Study},
  journal = {Pediatric Anesthesia},
  year = {2025},
  doi = {10.1111/pan.70031}
}
Kostenlos starten →